) Request for tender - RFT26-003 Wadandi Track Construction. Published on Friday, 24 April 2026 at 1.12.06 PM ... All tender submissions must be received by 2.00pm (AWST) on Friday 22 May 2026 ... Giving Statewide public notice of the invitation to tender.
) Construction of Wadandi TrackTender. The Shire of AugustaMargaret River is seeking tenders from appropriate parties for the construction of Sections 8-11 of the Wadandi Track ... Tender RFT 26-003 WADANDI TRACK CONSTRUCTION, SECTIONS 8-11 & 20-22.
"BPL-003SalesForecast" ... DelveInsight’s comprehensive analysis of BPL-003 sales, BPL-003 sales forecast, BPL-003 cost, and BPL-003 price trends provides valuable insights for stakeholders looking to capitalize on this high-growth opportunity.
In this multicenter, open-label Phase 1b study (NCT06395285), six adult patients with genetically confirmed ROSAH syndrome associated with the ALPK1 T237M mutation received once-daily oral DF-003 treatment for four weeks ... About DF-003.
). Notice of 2026 Annual Meeting and ProxyStatement. We're Brighthouse Financial. We are on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,1...Best's Review®. Top 200 U.S ... 69.
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohortsDurable responses observed at Day 85. 83% (5/6) (10 mg) and 66.7% (4/6) ... .
BPL-003 was generally well tolerated with no serious adverse events reported, and participants achieved a mean discharge approximately 100 minutes post-dose.
) 66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohorts Durable responses observed at Day 85 ... About BPL-003.